The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke
Open accessAbstract
Transplantation of human mesenchymal stem cells has been shown to reduce infarct size and improve functional outcome in animal models of stroke. Here, we report a study designed to assess feasibility and safety of transplantation of autologous human mesenchymal stem cells expanded in autologous human serum in stroke patients. We report an unblinded study on 12 patients with ischaemic grey matter, white matter and mixed lesions, in contrast to a prior study on autologous mesenchymal stem cells expanded in foetal calf serum that focused on grey matter lesions. Cells cultured in human serum expanded more rapidly than in foetal calf serum, reducing cell preparation time and risk of transmissible disorders such as bovine spongiform encephalomyelitis. Autologous mesenchymal stem cells were delivered intravenously 36-133 days post-stroke. All patients had magnetic resonance angiography to identify vascular lesions, and magnetic resonance imaging prior to cell infusion and at intervals up to 1 year after. Magnetic resonance perfusion-imaging and 3D-tractography were carried out in some patients. Neurological status was scored using the National Institutes of Health Stroke Scale and modified Rankin scores. We did not observe any central nervous system tumours, abnormal cell growths or neurological deterioration, and there was no evidence for venous thromboembolism, systemic malignancy or systemic infection in any of the patients following stem cell infusion. The median daily rate of National Institutes of Health Stroke Scale change was 0.36 during the first week post-infusion, compared with a median daily rate of change of 0.04 from the first day of testing to immediately before infusion. Daily rates of change in National Institutes of Health Stroke Scale scores during longer post-infusion intervals that more closely matched the interval between initial scoring and cell infusion also showed an increase following cell infusion. Mean lesion volume as assessed by magnetic resonance imaging was reduced by >20% at 1 week post-cell infusion. While we would emphasize that the current study was unblinded, did not assess overall function or relative functional importance of different types of deficits, and does not exclude placebo effects or a contribution of recovery as a result of the natural history of stroke, our observations provide evidence supporting the feasibility and safety of delivery of a relatively large dose of autologous mesenchymal human stem cells, cultured in autologous human serum, into human subjects with stroke and support the need for additional blinded, placebo-controlled studies on autologous mesenchymal human stem cell infusion in stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Adult rat and human bone marrow stromal cells differentiate into neurons
Woodbury, D., Schwarz, E. J., Prockop, D. J., & Black, I. B. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000815)61:4<364::aid-jnr2>3.0.co;2-c · Cited by 2,434
Koç, O. N., Gerson, S. L., Cooper, B. W., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I., & Lazarus, H. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.307 · Cited by 1,119
Autologous mesenchymal stem cell transplantation in stroke patients
Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005) · Annals of Neurology · doi:10.1002/ana.20501 · Cited by 1,102
Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery
Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., Katakowski, M., Zhang, L. J., Lu, M., Janakiraman, N., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.514 · Cited by 869
Lazarus, H. M., Koc, O. N., Devine, S. M., Curtin, P., Maziarz, R. T., Holland, H. K., Shpall, E. J., McCarthy, P., Atkinson, K., Cooper, B. W., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.02.001 · Cited by 803
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042604 · Cited by 709
Koç, O., Day, J., Nieder, M., Gerson, S., Lazarus, H., & Krivit, W. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703650 · Cited by 652
Chen, J., Zhang, Z. G., Li, Y., Wang, L., Xu, Y. X., Gautam, S. C., Lu, M., Zhu, Z., & Chopp, M. (2003) · Circulation Research · doi:10.1161/01.res.0000063425.51108.8d · Cited by 652
Treatment of neural injury with marrow stromal cells
Chopp, M., & Li, Y. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00040-6 · Cited by 624
Boulenguez, P., Liabeuf, S., Bos, R., Bras, H., Jean-Xavier, C., Brocard, C., Stil, A., Darbon, P., Cattaert, D., Delpire, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2107 · Cited by 617
Chen, J., Li, Y., Wang, L., Lu, M., Zhang, X., & Chopp, M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00557-3 · Cited by 527
Spees, J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., Hsu, S.-C., Smith, J., & Prockop, D. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.012 · Cited by 509
Shahdadfar, A., Frønsdal, K., Haug, T., Reinholt, F. P., & Brinchmann, J. E. (2005) · STEM CELLS · doi:10.1634/stemcells.2005-0094 · Cited by 501
Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome
Staba, S. L., Escolar, M. L., Poe, M., Kim, Y., Martin, P. L., Szabolcs, P., Allison-Thacker, J., Wood, S., Wenger, D. A., Rubinstein, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032613 · Cited by 478
Levine, E. S., Crozier, R. A., Black, I. B., & Plummer, M. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10235 · Cited by 412
Ohtaki, H., Ylostalo, J. H., Foraker, J. E., Robinson, A. P., Reger, R. L., Shioda, S., & Prockop, D. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803670105 · Cited by 387
Neumann-Haefelin, T., Kastrup, A., de Crespigny, A., Yenari, M. A., Ringer, T., Sun, G. H., & Moseley, M. E. (2000) · Stroke · doi:10.1161/01.str.31.8.1965 · Cited by 347
Prockop, D. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100313 · Cited by 315
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia
Liu, H. (2006) · Brain · doi:10.1093/brain/awl207 · Cited by 291
Nomura, T., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.062 · Cited by 258
Self-citationOnda, T., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600527 · Cited by 238
Self-citationHonma, T., Honmou, O., Iihoshi, S., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.05.004 · Cited by 230
Self-citationFreedman, M. S., Bar-Or, A., Atkins, H. L., Karussis, D., Frassoni, F., Lazarus, H., Scolding, N., Slavin, S., Le Blanc, K., Uccelli, A., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509359727 · Cited by 219
Horita, Y., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21056 · Cited by 216
Self-citationToyama, K., Honmou, O., Harada, K., Suzuki, J., Houkin, K., Hamada, H., & Kocsis, J. D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.010 · Cited by 139
Self-citationNeural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells
Kim, S., Honmou, O., Kato, K., Nonaka, T., Houkin, K., Hamada, H., & Kocsis, J. D. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.044 · Cited by 127
Self-citationMesenchymal Stem Cells Derived from Peripheral Blood Protects against Ischemia
Ukai, R., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0161 · Cited by 118
Self-citationOmori, Y., Honmou, O., Harada, K., Suzuki, J., Houkin, K., & Kocsis, J. D. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.116 · Cited by 111
Self-citationTherapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia
Komatsu, K., Honmou, O., Suzuki, J., Houkin, K., Hamada, H., & Kocsis, J. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.006 · Cited by 104
Self-citationTucker, K. R., & Fadool, D. A. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.017376 · Cited by 101
Establishing Final Infarct Volume
Gaudinski, M. R., Henning, E. C., Miracle, A. C., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.512269 · Cited by 100
Kobune, M., Kawano, Y., Ito, Y., Chiba, H., Nakamura, K., Tsuda, H., Sasaki, K., Dehari, H., Uchida, H., Honmou, O., et al. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00177-2 · Cited by 96
Self-citationAbe, K., Hayashi, T., & Itoyama, Y. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00517-x · Cited by 87
Rogalski, S. L., Appleyard, S. M., Pattillo, A., Terman, G. W., & Chavkin, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000183200 · Cited by 70
On recovering syntenic blocks from comparative maps
Chen, Z., Fu, B., Jiang, M., & Zhu, B. (2009) · Journal of Combinatorial Optimization · doi:10.1007/s10878-009-9233-x · Cited by 56
Sharma, H. S., & Johanson, C. E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.008 · Cited by 51
SHARMA, H. S. (2003) · Springer eBooks · doi:10.1007/978-3-7091-0651-8_81 · Cited by 50
Mizoguchi, Y., Monji, A., & Nabekura, J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02198.x · Cited by 35
Autologous mesenchymal bone marrow stem cells: Practical considerations
Scolding, N. J., Marks, D. I., & Rice, C. M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.009 · Cited by 23
Human Mesenchymal Stem Cell Culture for Neural Transplantation
Gordon, D., & Scolding, N. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-931-4_8 · Cited by 14
Honmou, O. (2008) · Stroke · Cited by 11
Self-citation
Cited by
Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., Granton, J., Stewart, D. J., & Canadian Critical Care Trials Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0047559 · Cited by 1,146
Stem cell-based therapy for human diseases
Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01134-4 · Cited by 1,074
Mesenchymal stem cells: a new trend for cell therapy
Wei, X., Yang, X., Han, Z.-P., Qu, F.-F., Shao, L., & Shi, Y.-F. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.50 · Cited by 942
Doeppner, T. R., Herz, J., Görgens, A., Schlechter, J., Ludwig, A.-K., Radtke, S., de Miroschedji, K., Horn, P. A., Giebel, B., & Hermann, D. M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0078 · Cited by 772
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Sharma, R. R., Pollock, K., Hubel, A., & McKenna, D. (2014) · Transfusion · doi:10.1111/trf.12421 · Cited by 430
Metadata
- Authors
- Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., Waxman, S. G., & Kocsis, J. D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04-14
- Volume
- 134
- Issue
- 6
- Pages
- 1790-1807
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2108896478
- Cited by
- 494
- References
- 42
- FWCI
- 20.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.